Effects of Bariatric Endoscopy on Non-Alcoholic Fatty Liver Disease: A Comprehensive Systematic Review and Meta-Analysis

Effects of Bariatric Endoscopy on Non-Alcoholic Fatty Liver Disease: A Comprehensive Systematic Review and Meta-Analysis

Background and objectiveEndoscopic bariatric and metabolic therapies (EBMTs) are emerging minimally invasive therapeutic options for obesity and its related complications, including non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the effects of EBMTs on NALFD in patients with...

Full description

Bibliographic Details
Main Authors:	Mengting Ren, Xinxin Zhou, Yunyun Zhang, Feifei Mo, Jinpu Yang, Mosang Yu, Feng Ji
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Endocrinology
Subjects:	endoscopy non-alcoholic fatty liver disease (NAFLD) bariatrics liver function tests meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.931519/full

Similar Items

Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality
by: Yi Xia, et al.
Published: (2022-09-01)

Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management
by: Anja Geerts, et al.
Published: (2023-02-01)

Functional-morphological changes in non-alcoholic fatty liver disease after bariatric operations
by: Iu. I. Sedletskii, et al.
Published: (2019-02-01)

Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease—A Meta-Analysis
by: Karolina Jakubczyk, et al.
Published: (2020-08-01)

Bariatric surgery for patients with non-alcoholic fatty liver disease: A bibliometric analysis based on Web of Science
by: Si-Ke He, et al.
Published: (2024-03-01)

Is Helicobacter pylori infection associated with non-alcoholic fatty liver disease in individuals undergoing bariatric surgery? Cross-sectional study
by: Erick Coelho Valadares, et al.
Published: (2023-04-01)

Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
by: Tarang Taghvaei, et al.
Published: (2023-12-01)

Prevalence of Non Alcoholic Fatty Liver Disease in patients with Parkinson Disease
by: Selahattin Vural, et al.
Published: (2019-04-01)

Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease
by: Ye Eun Cho, et al.
Published: (2023-03-01)

Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis
by: Marco Castellana, et al.
Published: (2021-04-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
by: Laura Valenzuela-Vallejo, et al.
Published: (2023-05-01)

Prevalence of Corneal Arcus in Patients Younger Than 50 Years with Non-Alcoholic Fatty Liver Disease in Gorgan, Northeast of Iran
by: Negar Broomand, et al.
Published: (2017-10-01)

Effects of sleeve gastrectomy and Roux-en-Y gastric bypass on non-alcoholic fatty liver disease in Iranians with morbid obesity
by: Ladan Aghakhani, et al.
Published: (2023-07-01)

Editorial: The broader aspects of non-alcoholic fatty liver disease in children
by: Claudia Mandato, et al.
Published: (2022-10-01)

Effect of pioglitazone on nonalcoholic fatty liver disease in morbid obese patients; a randomized controlled trial
by: Masoud Sayadishahraki, et al.
Published: (2023-01-01)

RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: Lourianne Nascimento CAVALCANTE, et al.
Published: (2022-11-01)

The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients
by: Charlotte W. Wernberg, et al.
Published: (2021-03-01)

Prevalence of non-alcoholic fatty liver disease among diabetes, prediabetes and healthy population
by: Pratyush Kumar, et al.
Published: (2022-01-01)

Bariatric surgery in liver cirrhosis
by: A. S. Mehdorn, et al.
Published: (2022-12-01)

Alcohol consumption and risk of fatty liver disease: a meta-analysis
by: Guoli Cao, et al.
Published: (2016-10-01)

Exercise Does Not Independently Improve Histological Outcomes in Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: George Chen, et al.
Published: (2023-09-01)

Effect of mediterranean diet on non-alcoholic fatty liver disease (NAFLD)
by: Patrycja Walczak, et al.
Published: (2023-01-01)

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)

Prevalence and associated factors for non-alcoholic fatty liver disease among adults in the South Asian Region: a meta-analysisResearch in context
by: Madunil Anuk Niriella, et al.
Published: (2023-08-01)

Influence of surgical treatment of obesity on the course of nonalcoholic fatty liver disease
by: A. S. Pushkareva, et al.
Published: (2023-11-01)

Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
by: Maria Cerreto, et al.
Published: (2021-07-01)

The Impact of Bariatric-Surgery-Induced Weight Loss on Patients Undergoing Liver Transplant: A Focus on Metabolism, Pathophysiological Changes, and Outcome in Obese Patients Suffering NAFLD-Related Cirrhosis
by: Gerardo Sarno, et al.
Published: (2022-09-01)

Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
by: Chia-Jung Liao, et al.
Published: (2022-05-01)

Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments?
by: Eva Juárez-Hernández, et al.
Published: (2022-11-01)

Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)
by: Adnan Khan, et al.
Published: (2022-10-01)

Frequencies of Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Lean Individuals
by: Anum Rasheed, et al.
Published: (2024-04-01)

Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
by: Saverio Nucera, et al.
Published: (2023-11-01)

Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury
by: Estefanía Caballano-Infantes, et al.
Published: (2021-12-01)

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review
by: Aitor Odriozola, et al.
Published: (2023-04-01)

Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver disease
by: Huan Zhang, et al.
Published: (2023-12-01)

Nutrient patterns and non-alcoholic fatty liver disease in Iranian Adul: A case-control study
by: Ammar Salehi-sahlabadi, et al.
Published: (2022-09-01)

Co-morbidities associated with Non Alcoholic Fatty Liver Disease in Tertiary Care Hospital of central India
by: S Divekar, et al.
Published: (2016-01-01)